| Literature DB >> 32731991 |
Yi-Tei Wu1, Wen-Yuan Yang2, Yi-Hsieng Samuel Wu1, Jr-Wei Chen3, Yi-Chen Chen4.
Abstract
Salmonellosis in broilers is not merely a significant disease with high economic costs in the poultry industry but also the foodborne disease with the impact on public health by cross-contamination. This study was to investigate the prebiotic ability of trehalose supplementing in diets (0, 1, 3, and 5%, w/w) against Salmonella by using S. Typhimurium (ST)-inoculated broilers. The improvements (P < 0.05) of feed conversion ratio (FCR) were observed with 5% trehalose supplementation in ST-inoculated broilers' diets. An addition of 3 or 5% trehalose in diets increased (P < 0.05) the abundance of lactobacilli in the duodenum and jejunum but decreased (P < 0.05) the growth of ST in the cecum. The adverse effects on serum levels of aspartate aminotransferase, triglyceride, and albumin and globulin ratio in ST-inoculated broilers were noticed and counteracted by supplementing 3 or 5% trehalose in diets (P < 0.05). Besides, the inclusion of trehalose in diets alleviated the intestinal damages and maintained the integrity of cecal epithelial cells after ST challenge under an haematoxylin and eosin-staining observation. Supplementing trehalose further showed the inhibitions of toll-like receptor 4-mediated nuclear factor-kappa-B pathway, including the downregulation (P < 0.05) of proinflammatory cytokine genes, such as interleukin 1 beta and lipopolysaccharide-induced tumor necrosis factor-alpha factor and the upregulation (P < 0.05) of interleukin 10 and interferon-alpha in ST-inoculated broilers. Overall, supplementing trehalose alleviated the adverse effects from ST challenge on FCR, serum biochemistry, the damage, and inflammation in the liver and cecum. Those improvements on ST challenged broilers also contributed to the overgrowth of lactobacilli, the decrement of ST, and anti-inflammatory effects in affected broilers. Trehalose, therefore, could be a promising prebiotic against salmonellosis to benefit broiler production and promote food safety in the poultry industry.Entities:
Keywords: Salmonella Typhimurium; anti-inflammation; broilers; lactobacillus; trehalose
Year: 2020 PMID: 32731991 PMCID: PMC7597916 DOI: 10.1016/j.psj.2020.03.053
Source DB: PubMed Journal: Poult Sci ISSN: 0032-5791 Impact factor: 3.352
Effects of trehalose (Treh) on daily weight gain, daily feed intake, feed conversion ratio (FCR), and mortality of broilers during the periods of preinoculation and postinoculation of Salmonella Typhimurium (ST).
| Treatment | Control | 0% Treh + ST | 1% Treh + ST | 3% Treh + ST | 5% Treh + ST | SEM | |
|---|---|---|---|---|---|---|---|
| Body weight (BW, g/broiler/pen) | |||||||
| Day 1 | 40.6a | 39.6a | 40.8a | 40.7a | 40.6a | 0.36 | 0.769 |
| Day 28 | 1511.7a | 1495.8a | 1493.4a | 1480.1a | 1413.6a | 19.63 | 0.442 |
| Day 35 | 2134.2a | 2097.8a | 2131.0a | 2102.0a | 2008.4a | 25.66 | 0.421 |
| Daily BW gain (DBWG, g/broiler/pen) | |||||||
| Day 1–28 | 52.2a | 50.9a | 51.3a | 51.9a | 49.1a | 0.70 | 0.445 |
| Day 29–35 | 91.5a | 88.2a | 90.7a | 92.7a | 84.4a | 4.34 | 0.966 |
| Daily feed intake (g/broiler/pen) | |||||||
| Day 1–28 | 74.2a | 72.5a | 74.4a | 74.8a | 71.2a | 1.42 | 0.197 |
| Day 29–35 | 157.0b | 194.8a | 194.9a | 192.9a | 154.4b | 7.70 | 0.005 |
| Feed conversion ratio (g feed/g BW) | |||||||
| Day 1–28 | 1.44a | 1.41a | 1.41a | 1.46a | 1.46a | 0.02 | 0.466 |
| Day 29–35 | 1.65b | 2.23a | 2.20a | 2.11a | 1.83b | 0.08 | 0.002 |
| Number of dead broiler in the trial | |||||||
| 0 | 0 | 0 | 1 | 1 | |||
a,bMean value in the same row without the common letter was significantly different (P < 0.05).
The data were given as mean (n = 15 for BW in all groups during the experimental period, except n = 14 for day 28 and day 35 BW of both 3% Treh + ST and 5% Treh + ST groups because of the broiler death; n = 3 for DBWG, feed intake, and feed conversion ratio).
Effects of trehalose (Treh) on the abundance of Salmonella Typhimurium (ST) in the small intestines, cecum, and feces of broilers orally challenged with or without ST on day 35 (Unit: log CFU/g).
| Treatment | Control | 0% Treh + ST | 1% Treh + ST | 3% Treh + ST | 5% Treh + ST | SEM | |
|---|---|---|---|---|---|---|---|
| Duodenum | ND | ND | ND | ND | ND | ||
| Jejunum | ND | ND | ND | ND | ND | ||
| Ileum | ND | ND | ND | ND | ND | ||
| Cecum | ND | 5.12a | ND | ND | 4.86b | 0.10 | <0.000 |
| Feces | ND | 4.97a | 4.77a | ND | 4.66a | 0.08 | <0.000 |
a,bMean value in the same row without the common letter was significantly different (P < 0.05).
The data were given as mean (n = 8 for duodenum, jejunum, ileum, and cecum; n = 9 for feces).
ND, not detectable indicated the value was less than 104 CFU/g.
Effects of trehalose (Treh) on the abundance of lactobacilli in the small intestines, cecum, and feces of broilers orally challenged with or without Salmonella Typhimurium (ST) on day 35 (Unit: log CFU/g).
| Treatment | Control | 0% Treh + ST | 1% Treh + ST | 3% Treh + ST | 5% Treh + ST | SEM | |
|---|---|---|---|---|---|---|---|
| Duodenum | 10.86b | 9.82c | 11.15a,b | 11.91a | 10.93b | 0.16 | 0.003 |
| Jejunum | 11.54b | 10.49c | 11.30b | 12.48a | 11.21b | 0.12 | 0.000 |
| Ileum | 12.86a | 11.61b | 11.70b | 12.54a | 12.09b | 0.12 | 0.023 |
| Cecum | 10.29b,c | 9.62c | 10.91a,b | 11.67a | 10.64a,b | 0.17 | 0.008 |
| Feces | 12.73a | 12.59a | 12.87a | 12.50a | 12.49a | 0.09 | 0.936 |
a–cMean value in the same row without the common letter was significantly different (P < 0.05).
The data were given as mean (n = 8 for duodenum, jejunum, ileum, and cecum; n = 9 for feces).
Effects of trehalose (Treh) on serum biochemistry of broilers orally challenged with or without Salmonella Typhimurium (ST).
| Treatment | Control | 0% Treh + ST | 1% Treh + ST | 3% Treh + ST | 5% Treh + ST | SEM | |
|---|---|---|---|---|---|---|---|
| AST (IU/L) | 202.25a | 251.23a | 215.29a | 222.50a | 233.55a | 6.26 | 0.157 |
| ALT (IU/L) | 5.58b,c | 12.31a | 6.54b | 7.78b | 3.31c | 0.47 | <0.000 |
| TG (mg/dL) | 88.33a | 23.15c | 27.67c | 51.50b | 63.31b | 2.78 | <0.000 |
| TC (mg/dL) | 132.4a | 137.21a | 134.79a | 146.18a | 151.08a | 3.67 | 0.454 |
| Total protein (g/dL) | 3.08a | 3.57a | 3.39a | 3.48a | 3.68a | 0.09 | 0.288 |
| Albumin (g/dL) | 1.34a | 1.44a | 1.36a | 1.48a | 1.54a | 0.04 | 0.502 |
| Globulin (g/dL) | 1.74a | 2.14a | 2.04a | 2.00a | 2.15a | 0.05 | 0.128 |
| A/G ratio | 0.78a | 0.65c | 0.68b,c | 0.74a,b | 0.74a,b | 0.01 | 0.009 |
a–cMean value in the same row without the common letter was significantly different (P < 0.05).
The data were given as mean (n = 15 for Control, 0% Treh + ST, and 1% Treh + ST groups; n = 14 for 3% Treh + ST and 5% Treh + ST groups).
Abbreviations: Treh, Trehalose; AST, aspartate aminotransferase; ALT, alanine transaminase; TG, triglyceride; TC, total cholesterol; A/G ratio, albumin and globulin ratio.
Figure 1Histopathological examinations of cecal tissues from broilers with or without the challenge of Salmonella Typhimurium (ST) by haematoxylin and eosin staining. (A) Control group; (B) 0% Treh + ST group; (C) 1% Treh + ST group; (D) 3% Treh + ST group; (E) 5% Treh + ST group. The scales were shown in 20 μm (400×), 100 μm (100×), and 200 μm (40×). The infiltration of immune cells was indicated by the black arrow.
Figure 2Effects of trehalose (Treh) on the expression of inflammatory-related cytokine genes in cecal tissues of broilers with the challenge of Salmonella Typhimurium (ST). (A) NFκB1A; (B) IL-1β; (C) IL-6; (D) IL-12β; (E) IFNγ; (F) LITAF; (G) IL-10; (H) IFNα. The data were presented by mean of fold change ± SEM (n = 8). Mean value without the common letter on data bar in each figure indicated that the difference was significant (P < 0.05). Abbreviations: IFNα, interferon alpha; IFNγ, interferon gamma; IL-1β, interleukin-1 beta; IL-6, interleukin-6, IL-10, interleukin 10;IL-12β, interleukin-12 beta; LITAF, lipopolysaccharide-induced tumor necrosis factor-alpha factor; NFκB1A, nuclear factor-kappa-B-inhibitor alpha.
Figure 3Beneficial effects of trehalose supplementation against the S. Typhimurium (ST) infection in the cecum of broilers. Abbreviations: A/G ratio, albumin/globulin ratio; IFNα, interferon alpha; IL-1β, interleukin-1 beta; IL-10, interleukin 10.